Ono Pharmaceutical Adds AI Agents to Drug Research

The company is partnering with a startup called Phylo to use their research platform. This system is designed to help scientists manage their daily computing tasks more efficiently. It tracks the history of each project and handles data to save researchers time.

By using these AI agents, the team hopes to work faster in the early stages of discovery. The platform acts like a digital assistant that keeps track of complex information. This helps the researchers focus on the most important parts of their work.

This shift shows how drug companies are changing their approach to medicine. Instead of doing everything manually, scientists can now rely on technology to handle the heavy lifting. This collaboration could lead to new treatments hitting the market sooner.